Introduction
As with all new and expensive techniques in medicine the development of in vitro fertilization (IVF) presents the providers of health care with several problems. There is considerable pressure to provide the service from infertile couples, as well as gynaecologists who wish to extend the range of services they provide and who see at first hand the distress caused by infertility. The media know that the happiness of a couple on the birth of their child, conceived with such great difficulty, will be shared by their readers and that the corollary of this shared happiness is a widespread sympathy for couples who are unable to conceive.
If the new technique is widely taken up by the private sector, as is the case with IVF, then inequality of distribution becomes a problem. The NHS, whose aim is to provide equity of distribution of services, is faced with the glaring inequality of a service which is available to those who can afford to pay but not to the less well off unless they are lucky enough to live within the catchment area ofone ofthe few NHS units or a unit based in a research-funded University department.
In order to make rational decisions about the development of new services information is needed about the demand for those services, the costs and the likely outcome of service provision. The paradox is that such information is not forthcoming until the service is actually provided on a reasonably large scale in an NHS setting. This paper summarizes the work done tow assist Trent Regional Health Authority in deliberations about the funding of IVF.
Sheffield, within the Trent Region. This unit is fumded by research money and by patients who can afford to pay a nominal fee. Table 1 indicates the running costs of an IVF unit. The three units costed are characterized by the letters X, Y and Z because rather than using actual levels of expenditure in the inaugural phase when activity was low in relation to expenditure, adjustments were made in the costings from the three units to take account of their expected levels of activity and resource use if funds were provided.
The costs of IVF
The staff costs were derived from the different staffng levels and structures proposed by the three units, taking into account overheads such as superannuation and National Insurance contributions. In the inaugural stages of setting up an IVF clinic the consultant is likely to be involved almost full time in this work but once the clinic is established the consultant should provide managerial supervision and a limited clinical input which will probably account for three or four sessions each week. Therefore only one-third wholetime equivalent of a consultant gynaecologist's time is costed here. The cost of drugs and consumables depends on the drug regimen used in the follicular phase of the IVF cycle. Whereas most practitioners use follicular stimulants such as Pergonal and clomiphene for all women, one of the three units costed prefers to use unstimulated cycles where possible. The units also varied in their use of human chorionic gonadotrophin in the luteal phase.
What should be costed? There were three different options available for the costing of IVF. These were: (1) The cost of setting up a complete infertility service, including IVF, from scratch. (2) The cost of adding IVF on a large scale to an already existing specialist infertility service. (3) The marginal cost oftreating an additional couple in an already existing IVF unit. Option 2 was chosen because it was thought that if IVF were to develop in the NHS it would be as an extension of the services offered at already existing specialist infertility clinics.
Information was obtained from two Regional Health Authorities; the North Western, which provides an IVF service fumded by the NHS based on St Marys Hospital, Manchester, and the South Western Region where gynaecologists in two Health Districts have initially developed IVF within existing resources and then requested that NHS funds be made available for the expansion of the service. Information was also obtained from the IVF unit based at Jessop Hospital, The use of consumables varied depending on the methods used and the intensity of monitoring changes in hormone levels in serum, saliva and urine in the pre-ovulatory phase.
The costs for utilization of hospital facilities were based on half the average cost of one overnight stay, per cycle. Most units attempt to keep inpatient stays to a minimum but even where no inpatient stay is incurred, the patient still has use of the facilities and general services of the hospital, such as heating, lighting, maintenance, portering, laundry, etc. The average cost per inpatient day was obtained from two large gynaecological units in Sheffield; the average of the two was £106 per day. This cost includes treatment; for IVF patients the treatment costs are included in the IVF costing, therefore the cost per day in IVF was taken to be £53. Patients were assumed to use hospital facilities to this value whether or not they actually stayed overnight.
The annual equivalent cost of building was based on the floor area of 252 m2 of one of the IVF units costed. This floor space was costed: (a) on the basis of a new building costing £318 000 (including fees, on-cost, furnishing and basic equipment) discounted over the 60 year life ofthe building to give an annual equivalent cost of £16 000 per annum. (b) a conversion of an old building costing £200 000 (this is the cost ofthe conversion plus the opportunity cost of the foregone opportunity to sell the building or use it for another purpose) discounted over the average life of a converted building of 20 years to give an annual equivalent cost of £16 000. The annual equivalent cost of equipment was based on costs of equipment specifically for IVF which came to £77 928. This equipment would require replacement at intervals over a period of 20 years. The total net present value of equipment and replacement costs equals £155 853 which discounted over 20 years gives an annual present value of £7793.
The average annual cost of IVF was calculated by adding together the estimated costs ofthe three units and dividing by the total number of cycles of treatment which the units would offer to give a cost of £366 per cycle of treatment. For a unit aiming to treat approximately 400 couples per annum and to provide three cycles of treatment (on average) for each couple, the average annual cost of IVF would be £439 739.
The stream of costs Although it is important to consider the annual equivalent cost of buildings for the provision of services, this may be thought to present an unrealistic picture. Rather than providing an annual equivalent cost each year for the building, the Health Authority is usually presented with a large capital outlay required to set-up the service. Table 2 illustrates the costs of provision of an IVF service year by year. The cost in the first year(s) will be the capital cost of either a new building or a conversion of an old building. The cash outlay for a conversion will be only the cost of carrying out the conversion and not the foregone opportunity cost of an alternative use or sale of the building.
In year two, equipment and staff costs will be incurred but it is unlikely that the unit will treat its full annual quota of patients in that year, therefore the costs for the second year have been based on a fully staffed and equipped unit aiming eventually to carry out 1200 cycles per year, carrying out in its first year of operation 600 cycles. In the 3rd, 4th and 5th year, the unit can be expected to carry out 1200 cycles per annum. In the 6th year, a large bill is expected for equipment replacement.
Thus the use of a stream of costs approach shows a lower annual cost for the established unit but with the very large capital outlay required initially at a time when no patients are treated.
The effectiveness of IVF There are many ways of presenting the outcome of in vitro fertilization. The numerator used may be the number ofpregnancies (the term clinical pregnancy is usually used and is defined as a distinct rise in beta HCG continuing until at least 28 days after oocyte recovery and/or the appearance of a gestation sac on ultrasound)'. The apparent incidence of spontaneous abortion is higher among IVF pregnancies than among normally conceived pregnancies2, mainly due to the fact that IVF pregnancies are diagnosed earlier. However, it means that in assessing the chance ofhaving a baby, the pregnancy rate is misleading unless the relatively high abortion rate is taken into account. An alternative numerator is the number of births. Since the incidence oftwin or triplet births is considerably higher in IVF than in normal reproduction2 there are more births than there are mothers, some mothers having 2 or 3 babies. Given the distribution of twin and triplet births among IVF pregnancies in Australia2, it is likely that the number of babies will exceed the number of maternities by 25%. Since for couples embarking on IVF the success rate might be viewed in terms of the likelihood of having at least one baby, it is suggested that the number of maternities is the most useful numerator from this point of view. The choice of denominator is also crucial. It is customary to present the success rates of IVF in terms of either patients accepted for treatment or cycles of treatment. (Other less useful denominators are the number of laparoscopies performed or the number of embryo transfers performed.) For a couple embarking on IVF treatment especially ifNHS funded, in which case the number of cycles oftreatment would be rationed externally rather than by the couple's ability to pay, the most useful denominator is the number of couples accepted for treatment.
Thus the success rate here is expressed in terms of a maternity rate: number of maternities xlOO couples accepted for treatment Maternity rates from IVF in the UK The Report of the Voluntary Licensing Authority (1987) giving information from IVF carried out in 1985 indicates that the maternity rate achieved is 7.4% in new clinics (those established since 1984) and 10.6% in clinics established before 1984.
The average number ofcycles per couple in the UK in 1985 was 1.63. Undoubtedly these maternity rates will improve as data become available from further cycles offered to these couples, although it must not be assumed that the maternity rate will increase commensurately with the number of cycles offered, since statistically those with a better chance ofsuccess will become pregnant in the earlier attempts. Early attempts may also reveal for some couples that success is unlikely -they will be advised not to continue. Other couples may drop out because they find the procedure too stressful. Presumably couples treated in established clinics were likely to have had more cycles of treatment than those in new clinics.
Thus it seems reasonable to expect that approximately 10% of couples accepted for IVF treatment would achieve a maternity.
The cost effectiveness of IVF Table 3 shows, for the treatment of 400 couples at a success rate of 10%, the cost per couple treated, per maternity and per baby. The units for which costs were obtained had different approaches to cost reduction but the main efforts to minimize costs centred on four aspects of the process. In one unit, as already described, natural rather than stimulated cycles were used where possible. All the units stated that they kept inpatient stays to a minimum, but the methods used for pre-ovulatory monitoring and for harvesting ova influence the extent to which inpatient stays can be reduced. New methods of hormone assay enable patients to collect samples of saliva or urine over a period of time and bring the batch of samples to the laboratory for testing. Although the consumables for this type of monitoring are more expensive, the fact that hospital facilities are used less and laboratory tests are batched brings about a reduction in the overall cost. The use of local anaesthetic rather than a general anaesthetic for harvesting ova by laparoscopy is now widely practised in IVF Clinics. This can be done on an outpatient basis, and reduces the time spent in hospital and the use of hospital facilities.
At present there is very little information on the influence ofthese cost reductions on outcome. The cost effectiveness of the procedure will only be improved by cost reductions if the effectiveness remains unchanged.
Increased effectiveness
The effectiveness of IVF can be improved by selection of patients whose cause of infertility is recognized to be amenable to treatment compared with other causes which are less readily treated by IVF, e.g. those with tubal blockage generally have higher levels of success than those whose infertility is unexplained4'5. Full investigation of both partners is necessary in order to establish the cause of infertility, if possible, and to eliminate factors which would prejudice treatment, such as the presence of sexually transmitted diseases6. Furthermore, the preparation ofthe pelvis to improve the accessibility of the ovaries may also improve effectiveness7. Changes in the techniques of IVF may also bring about improvements in success rates.
In any one clinic the numbers are too small to show significant differences in outcomes of different procedures8. It is only by large scale collaborative research between IVF units that patients can be treated in suffilciently large numbers to investigate the extent to which effectiveness can be improved in different types of patients9, and whether cost reductions can be achieved without reductions in effectiveness.
Costs in private vs public sector
Detailed investigation, surgical preparation and intensive monitoring all contribute to increased costs in IVF. It should be emphasized that this paper has reviewed the costs for adding IVF to an already established specialist infertility service where full investigation and pelvic microsurgery will normally be carried out in the course of investigation and treatment before the patient is deemed suitable for IVF.
Costs of IVF in the private sector are likely to be higher for two main reasons. One is that patients referred to private clinics may not have had the investigation and treatment which would, in an established NHS-specialist infertility service, normally precede IVF. Thus the private clinic may include these in its quoted costs for IVF treatment.
The cost of building space in the NHS has been calculated on the basis of a 60 year life for a new building or 20 years for a conversion. In the private sector the capital costs are recouped over a much shorter time span, e.g. 5 years, therefore the annual cost is much higher. Should IVF be provided by the NHS? Since many couples choose to be childless it is clearly not universally agreed that parenthood is a desirable state. It may be argued that infertile couples are 'not really ill' and therefore not deserving of NHS treatment. Consideration of the WHO classification of impairments, disabilities and handicaps may help in the comparison of infertility with other problems for which NHS treatment is readily provided. Infertile couples have a biological impairment which gives rise to a disability. Their handicap is the personal and social disadvantage they suffer in being unable to choose to comply with the social norm, or to take part in the culturally valued activities of childrearing, which they see their contemporaries enjoying.
The benefits of IVF are difficult to enumerate. With most treatments provided by the NHS, some benefits result for the majority of those treated. In IVF the benefits are differently distributed: the majority receive very little benefitperhaps only that of knowing they have done all they could, and possibly a more informed diagnosis. Those who do have a child have by contrast a total alleviation of their problem.
A further consideration must be whether or not the child produced by IVF can be said to benefit. If the life years of the child were to be considered then IVF would compete favourably with most NHS activities. However, an acceptance ofthe child's life as a benefit would carry uncomfortable implications as to the disbenefits of many fetuses which are aborted. It must be society's view that intervention cannot bring benefits or disbenefits to fetuses, only to their parents who are already existing members of society. Table 4 shows the cost of IVF compared with the costs of other procedures carried out in the NHS. Although it is impossible to compare costs and benefits directly in the absence of sufficient information about the benefits of IVF, this table indicates that IVF is not very expensive compared with many other procedures. Alternative sources of funding In the present financial climate it appears unlikely that NHS funding will be available to meet the demand for IVF. The service will probably develop with funding from patients, charitable foundations and research grants, from universities and private sources.
Costs of IVF compared with costs of other procedures
The NHS may contribute and work in collaboration with other agencies to provide a service. The involvement of the NHS may help to ensure equity of provision, and collaboration between units in research.
Conclusion
The cost of adding IVF on a scale of 1200 cycles of treatment per annum (providing on average 3 cycles of treatment to each of 400 couples), to an already existing specialist infertility service would be approximately £440 000 per annum, at an average cost per cycle of £366. Present success rates in established IVF clinics in the UK indicate that the treatment of 400 couples would result in 40 maternities, at a cost per maternity of £11000.
Costs in the private sector are greater because they may include elements of a specialist infertility service which have not been costed here, these facilities already being provided by NHS specialist infertility services. The private sector may also recoup building costs over a shorter period.
The benefits of IVF are difficult to enumerate and quantify so comparison with other procedures must be on the basis of costs and outcomes. It is unlikely that IVF will be fully funded by the NHS, although contribution to funding would enable the NHS to retain a degree of control over the distribution and development of the service.
